This monograph investigates the pharmacological mechanisms and toxicological profiles of amphetamines and emerging synthetic designer drugs. Khursheed Asghar, representing the National Institute on Drug Abuse, compiles technical research to establish a baseline for understanding the physiological impact of these substances. The text provides a framework for analyzing how chemical structural variations in designer drugs influence neurochemical pathways and clinical outcomes.

Experts recognize this monograph as a foundational technical resource for researchers and clinicians studying stimulant pharmacology. Readers frequently note the high density of biochemical data and the specialized nature of the research presented.